16 Recruiting Essential Thrombocythemia Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Essential Thrombocythemia
Related Conditions
Top Recruiting Essential Thrombocythemia Studies
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
📍 Palo Verde Cancer Specialists ( Site 0052) — Glendale, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance
📍 Mayo Clinic - Scottsdale — Scottsdale, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
📍 University of Miami — Miami, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)
📍 Palo Verde Hematology/ Oncology Center, Ltd. ( Site 3496) — Glendale, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Ruxolitinib in Thrombocythemia and Polycythemia Vera
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
📍 Banner Md Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔